Search Results - "Barbero Becerra, Varenka J."

Elevated cholesterol levels have a poor prognosis in a cholestasis scenario by Nuño‐Lámbarri, Natalia, Barbero‐Becerra, Varenka J, Uribe, Misael, Chávez‐Tapia, Norberto C

“…Cholestasis results from defective bile flow through the biliary ducts leading to the accumulation of bile acids (BAs) in hepatocytes and serum. It has been…”
Get full text

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents by Maldonado-Rojas, Andrea del Carmen, Zuarth-Vázquez, Julia María, Uribe, Misael, Barbero-Becerra, Varenka J

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by overweight/obesity, and the presence of type 2 diabetes mellitus is the…”
Get full text

Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level by Pérez-Monter, Carlos, Álvarez-Arce, Alejandro, Nuño-Lambarri, Natalia, Escalona-Nández, Ivonne, Juárez-Hernández, Eva, Chávez-Tapia, Norberto C, Uribe, Misael, Barbero-Becerra, Varenka J

“…Hepatic steatosis is characterized by triglyceride accumulation within hepatocytes in response to a high calorie intake, and it may be related to intestinal…”
Get full text

Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico by Aguilar-Zamora, Emmanuel, Weimer, Bart C, Torres, Roberto C, Gómez-Delgado, Alejandro, Ortiz-Olvera, Nayeli, Aparicio-Ozores, Gerardo, Barbero-Becerra, Varenka J, Torres, Javier, Camorlinga-Ponce, Margarita

“…is a global public health problem, which is a primary cause of antibiotic-associated diarrhea in humans. The emergence of hypervirulent and…”
Get full text

The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH by Barbero-Becerra, Varenka J., Giraudi, Pablo J., Chávez-Tapia, Norberto C., Uribe, Misael, Tiribelli, Claudio, Rosso, Natalia

“…•Global obesity epidemic dramatically increased the fatty liver disease prevalence.•In vitro models mimic liver microenvironment reproducing cellular responses…”
Get full text

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach by Nuño-Lámbarri, Natalia, Barbero-Becerra, Varenka J, Uribe, Misael, Chávez-Tapia, Norberto C

“…Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition that can progress to nonalcoholic steatohepatitis, cirrhosis and cancer. It is considered…”
Get full text

The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation by Giraudi, Pablo J., Barbero Becerra, Varenka J., Marin, Veronica, Chavez-Tapia, Norberto C., Tiribelli, Claudio, Rosso, Natalia

“…Non-alcoholic fatty liver disease is characterized by an initial accumulation of triglycerides that can progress to non-alcoholic steatohepatitis, which can…”
Get full text

Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients by López-Bautista, Fabiola, Barbero-Becerra, Varenka J., Ríos, María Yolanda, Ramírez-Cisneros, M. Ángeles, Sánchez-Pérez, Cristell A., Ramos-Ostos, Martha H., Uribe, Misael, Chávez-Tapia, Norberto C., Juárez-Hernández, Eva

“…Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Some dietary fatty acids have showed different bioactive functions…”
Get full text

Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind, multicentre, placebo controlled, randomised clinical trial by Romano-Munive, Adriana Fabiola, García-Correa, J Jesus, García-Contreras, Luis F, Ramírez-García, José, Uscanga, Luis, Barbero-Becerra, Varenka J, Moctezuma-Velázquez, Carlos, Ochoa-Rubí, Jorge A, Toledo-Cuque, Julio, Vázquez-Anaya, Gerardo, Keil-Ríos, Daniel, Grajales-Figueroa, Guido, Ramírez-Luna, Miguel Ángel, Valdovinos-Andraca, Francisco, Zamora-Nava, Luis Eduardo, Tellez-Avila, Felix

“…Background and study aimsPost-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a complication associated with important morbidity,…”
Get full text

Role of bioactive fatty acids in nonalcoholic fatty liver disease by Juárez-Hernández, Eva, Chávez-Tapia, Norberto C, Uribe, Misael, Barbero-Becerra, Varenka J

“…Nonalcoholic fatty liver disease (NAFLD) is characterized by fat deposition in hepatocytes, and a strong association with nutritional factors. Dietary fatty…”
Get full text

Silybin/Silymarin treatment in chronic hepatitis C by Varenka J. Barbero-Becerra, Nahum Méndez-Sánchez

Get full text

Vigorous, but differential mononuclear cell response of cirrhotic patients to bacterial ligands by Varenka J Barbero-Becerra María Concepción Gutiérrez-Ruiz Carmen Maldonado-Bernal Félix I Téllez-Avila Roberto Alfaro-Lara Florencia Vargas-Voràckovà

“…AIM： To study the role of gram-positive and gram-negative bacteria in the pathogenesis of liver injury, specifically the activation of inflammatory mediators…”
Get full text

Alcohol effects on liver diseases: good or bad buddy? by Barbero-Becerra, Varenka J, López-Velázquez, Jorge A, Sánchez-Valle, Vicente, Uribe, Misael, Méndez-Sánchez, Nahum

Get full text

Clostridioides Difficile in Latin America: An Epidemiological Overview by Morales-Olvera, Claudia G, Lanz-Zubiría, Lorena, Aguilar-Zamora, Emmanuel, Camorlinga-Ponce, Margarita, Aparicio-Ozores, Gerardo, Aguilar-Zapata, Daniel, Chávez-Tapia, Norberto C, Uribe, M, Barbero-Becerra, Varenka J, Juárez-Hernández, Eva

“…Clostridioides difficile infection is one of the most significant causes of nosocomial diarrhea associated with antibiotic use worldwide. In recent years, the…”
Get full text

G protein-coupled receptors: Key molecules in metabolic associated fatty liver disease development by López-Méndez, Iván, Méndez-Maldonado, Karla, Manzo-Francisco, Luis A., Juárez-Hernández, Eva, Uribe, Misael, Barbero-Becerra, Varenka J.

“…Metabolic associated fatty liver disease (MAFLD) is a range of hepatic disorders with progression to steatohepatitis with risk of development of fibrosis,…”
Get full text

Liver toxicity mechanisms of herbs commonly used in Latin America by López-Gil, Sofía, Nuño-Lámbarri, Natalia, Chávez-Tapia, Norberto, Uribe, Misael, Barbero-Becerra, Varenka J.

“…Mexico owns approximately 4500 medicinal plants species, a great diversity that position it at the second place after China. According to the Mexican health…”
Get full text

Sarcopenia in chronic liver diseases: a translational overview by Barbero-Becerra, Varenka J, López-Méndez, Iván, Romo-Araiza, Alejandra, Visag-Castillo, Víctor, Chávez-Tapia, Norberto C, Uribe, Misael, Juárez-Hernandez, Eva

“…Sarcopenia refers to a progressive and generalized muscle mass and strength loss. In liver diseases, it has been related to worse outcomes and high risk of…”
Get more information

Mo1846 Bilirubin As a Predictor of Short Term Prognosis in End Stage-Patients With Chronic Liver Disease by López-Velázquez, Jorge A, Barbero-Becerra, Varenka J, Sánchez-Valle, Vicente, Chavez-Tapia, Norberto C, Uribe, Misael, Mendez-Sanchez, Nahum

Get full text